Elsevier, KIT sign MoU to provide developing country researchers access to ScienceDirect and Scopus

NewsGuard 100/100 Score

- MoU Drives Research Usage and Access with Virtual Knowledge Community

Elsevier and the Royal Tropical Institute (KIT) in Amsterdam announced on 26th of August the signing of a Memorandum of Understanding (MoU) providing 150 researchers working in least-developed and low-income countries (for example Benin, Mozambique, Ethiopia, Togo etc.) with access to ScienceDirect and Scopus, Elsevier's online scientific research platform and flagship abstract and citation database. Active in fields such as tropical medicine and sustainable development, the scientists are able to apply the information available in ScienceDirect and Scopus to the treatment and prevention of diseases such as HIV/AIDS, malaria and tuberculosis; promoting rural development with improved water, sanitation and food security in addition to other areas relevant to the UN Millennium Development Goals.

Elsevier and KIT's department Information & Library Service (KIT ILS) in Amsterdam are collaborating on this unique public-private partnership to drive capacity building in information technology and management in the developing world. The new agreement will expand access for five years while sharing best practice in research and training.

As an integral part of this initiative, KIT ILS facilitates a closed Virtual Knowledge Community on information management to share best research practices and identify issues of common interest. First piloted in 2007, this joint Elsevier - KIT initiative provides the Virtual Knowledge Community members in African, Caribbean, Asian and Pacific countries with access to ScienceDirect's 10 million full-text articles and Scopus' abstract and citation database containing 18,000 peer-reviewed journals from 5,000 publishers.

"Elsevier and KIT have a long and productive relationship. The continuation of this initiative provides our partners in the South with access to a wealth of information that is directly relevant to their research. The association of the program with the Elsevier Foundation and Research4Life provides both recognition and sustainability. It is a privilege for KIT ILS to act as an intermediary in a co-operative effort that so closely matches our departmental and institutional goals," said Hans van Hartevelt, Director of KIT Information & Library Services. Jan Donner, CEO of KIT agrees: "This is a unique project which definitely matches our institutional goals. We are very proud that we can realize this together with Elsevier as an innovative co-partner."

"We are very happy to support the critical work that the Royal Tropical Institute is doing to drive access, usage and authorship in key developing world institutes, bringing key researchers closer to their peers and individual research communities around the world," said David Ruth, Executive Director of the Elsevier Foundation and Senior Vice President Global Communications, Elsevier. "This carefully targeted initiative is part of our overall effort with Research4Life and the Elsevier Foundation, to provide clinicians, researchers and policymakers in the developing world with access to the information they need to address critical health and sustainability challenges."

"Good news, extension of access to ScienceDirect and Scopus for five more years. I have been using ScienceDirect to obtain articles for our scientists and this is having a very positive impact on our research. For instance, our output of publications has continued to increase, thanks to access to many journal titles in ScienceDirect." Thomas Adigun, Head Librarian, Africa Rice Center, Cotonou, Benin.

"ScienceDirect is our sole full-text, up-to-date scientific database to which we have access. Our researchers have greatly benefited from it and it has become an essential source of information for us." Rose May Ng Kee Kwong, Librarian, MSIRI, Mauritius.

Source:

Royal Tropical Institute (KIT) and Elsevier

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer